📄 "Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment" . EBV lymphomas ( April 2, 2026 at 09:30AM)
https://pubmed.ncbi.nlm.nih.gov/41923627/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=07TGfd6xW8ejZCqVe2KpX2yGR1RKzfVyM7Wv85wXgoA&fc=None&ff=20260402083057&v=2.19.0.post6+133c1fe

📄 "A comparison of Epstein-Barr virus digital PCR and quantitative PCR for identifying nasopharyngeal cancer" . Vírus e Câncer ( April 1, 2026 at 08:25PM)
https://pubmed.ncbi.nlm.nih.gov/41920762/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260401192523&v=2.19.0.post6+133c1fe

📄 "Development and validation of a duplex droplet digital PCR assay for the simultaneous detection of cytomegalovirus and Epstein-Barr virus in plasma" . EBV ( April 6, 2026 at 04:14PM)
https://pubmed.ncbi.nlm.nih.gov/41938868/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260406151422&v=2.19.0.post6+133c1fe

📄 "Hit-and-run hypothesis: revisiting the impact of EBV in malignancies" . EBV ( April 9, 2026 at 10:21AM)
https://pubmed.ncbi.nlm.nih.gov/41953038/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260409092121&v=2.19.0.post6+133c1fe

📄 "Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics" . Vírus e Câncer ( April 10, 2026 at 09:55AM)
https://pubmed.ncbi.nlm.nih.gov/41958986/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260410085529&v=2.19.0.post6+133c1fe

📄 "EBV Genome Variations and Association With Diseases" . EBV ( April 13, 2026 at 08:28AM)
https://pubmed.ncbi.nlm.nih.gov/41969124/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260413072813&v=2.19.0.post6+133c1fe

📄 "EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk" . EBV ( April 16, 2026 at 08:39AM)
https://pubmed.ncbi.nlm.nih.gov/41986726/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260416073944&v=2.19.0.post6+133c1fe

📄 "Beyond the Usual Suspects: Emerging Associations Between Epstein-Barr Virus Infection/Infectious Mononucleosis and Cancers" . EBV ( April 25, 2026 at 08:47AM)
https://pubmed.ncbi.nlm.nih.gov/42033165/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260425074758&v=2.19.0.post6+133c1fe

📄 "Not so cold after all: tumor infiltrating CD8+ T cells in EBV-positive Burkitt lymphoma are quiescent, not exhausted" . EBV ( April 27, 2026 at 03:05PM)
https://pubmed.ncbi.nlm.nih.gov/42039670/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260427140530&v=2.19.0.post6+133c1fe

📄 "HIV and Cancer: Insights into Viral-Mediated Oncogenesis and Immunosuppression" . KSHV/HHV-8 ( May 4, 2026 at 08:28AM)
https://pubmed.ncbi.nlm.nih.gov/42075743/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260504072808&v=2.19.0.post6+133c1fe

📄 "Epstein-Barr Virus and Human Papillomavirus Co-Infections in Epithelial Carcinomas" . EBV ( April 22, 2026 at 08:06AM)
https://pubmed.ncbi.nlm.nih.gov/42015383/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260422070603&v=2.19.0.post6+133c1fe

📄 "An oncogenic role for EBV-encoded BILF1 in nasopharyngeal carcinoma" . EBV ( May 8, 2026 at 09:24AM)
https://pubmed.ncbi.nlm.nih.gov/42099008/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260508082438&v=2.20.0

📄 "NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma" . EBV ( May 14, 2026 at 08:09PM)
https://pubmed.ncbi.nlm.nih.gov/42133805/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260514190911&v=2.20.0

📄 "Epstein-Barr virus-encoded microRNAs: central players in nasopharyngeal and gastric carcinoma pathogenesis" . Vírus e Câncer ( May 17, 2026 at 10:37AM)
https://pubmed.ncbi.nlm.nih.gov/42143203/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260517093708&v=2.20.0

📄 "Epstein-Barr virus associated diseases: Immune alterations and targeted approaches" . EBV ( May 25, 2026 at 04:07PM)
https://pubmed.ncbi.nlm.nih.gov/42183201/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260525150757&v=2.20.0

📄 "A Host miRNA Signature Correlates With Clinical Stage Across Epstein-Barr Virus-Associated Malignancies" . EBV ( May 27, 2026 at 08:38AM)
https://pubmed.ncbi.nlm.nih.gov/42198896/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260527073827&v=2.20.0

📄 "CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus-associated B cell diseases" . EBV ( May 27, 2026 at 04:38AM)
https://pubmed.ncbi.nlm.nih.gov/42191836/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260527033816&v=2.20.0

📄 "Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression" . EBV ( May 27, 2026 at 12:59AM)
https://pubmed.ncbi.nlm.nih.gov/42189985/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260526235942&v=2.20.0

📄 "Epstein-Barr virus reprograms immune escape in nasopharyngeal carcinoma" . Vírus e Câncer ( May 26, 2026 at 09:45PM)
https://pubmed.ncbi.nlm.nih.gov/42186960/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260526204508&v=2.20.0

📄 "Epstein-Barr Virus Infection" . EBV ( May 20, 2026 at 05:42AM)
https://pubmed.ncbi.nlm.nih.gov/42156044/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260520044209&v=2.20.0

📄 "Immune Reprogramming by EBV and KSHV in the Tumour Microenvironment: From Mechanisms of Immune Escape to Immunotherapy" . KSHV/HHV-8 ( May 27, 2026 at 10:11PM)
https://pubmed.ncbi.nlm.nih.gov/42202101/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260527211145&v=2.20.0